CANEPARO, Valeria
CANEPARO, Valeria
SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE
Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.
2016-01-01 Alunno, Alessia ; Caneparo, Valeria; Bistoni, Onelia; Caterbi, Sara; Terenzi, Riccardo; Gariglio, Marisa; Bartoloni, Elena; Manzo, Antonio; Landolfo, Santo; Gerli, Roberto
Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy
2016-01-01 Caneparo, Valeria; Pastorelli, Luca; Pisani, Laura Francesca; Bruni, Barbara; Prodam, Flavia; Boldorini, Renzo; Roggenbuck, Dirk; Vecchi, Maurizio; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco
IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data
2019-01-01 Marino, Sonia; Gualtierotti, Roberta; Caneparo, Valeria; De Andrea, Marco; Gariglio, Marisa; Meroni, Pier Luigi; Bossi, Eleonora; Spadari, Francesco
IFI16 Autoantibodies
2013-01-01 Dell’Oste, Valentina; Caneparo, Valeria; De Andrea Marco; Gariglio, Marisa; Landolfo, Santo
Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease
2019-01-01 Manfredi, Marcello; Conte, Eleonora; Barberis, Elettra; Buzzi, Arianna; Robotti, Elisa; Caneparo, Valeria; Cecconi, Daniela; Brandi, Jessica; Vanni, Ester; Finocchiaro, Marco; Astegiano, Marco; Gariglio, Marisa; Marengo, Emilio; De Andrea, Marco
Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands.
2015-01-01 Alunno, Alessia; Caneparo, Valeria; Carubbi, A; Bistoni, O; Caterbi; Gariglio, M; Bartoloni, E; Landolfo, S; Gerli, R;
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis?
2015-01-01 Alunno, Alessia; Caneparo, Valeria; Carubbi, Francesco; Bistoni, Onelia; Caterbi, Sara; Bartoloni, Elena; Giacomelli, Roberto; Gariglio, Marisa; Landolfo, Santo; Gerli, Roberto
P178 Validation of the clinical utility of IFI16-based markers in IBD
2017-01-01 V. Caneparo, L. Pastorelli, E. Vanni, D. Roggenbuck, R. Boldorini, M. Astegiano, M. Vecchi, S. Landolfo, M. Gariglio, M. De Andrea
P600 Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD
2018-01-01 Caneparo, V; Verstockt, B; Vermeire, S; Landolfo, S; Gariglio, M; De Andrea, M
Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study
2021-01-01 Griffante G.; Chandel S.; Ferrante D.; Caneparo V.; Capello D.; Bettio V.; Borgogna C.; Aleni C.; Esposito S.; Sarro A.; Vasile A.; Comba M.; Testa T.; Cotrupi G.; De Andrea M.; Bortoluzzi S.; Gariglio M.
Relevance of Interferon-Inducible Protein-16 Rather than Anti-Interferon-Inducible Protein-16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren's Syndrome: Comment on the Article by Baer et al.
2017-01-01 Alunno, A; Bartoloni, E; Bistoni, O; Gerli, R; Caneparo, V; Carubbi, F; Landolfo, S
Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis
2020-01-01 De Andrea M.; De Santis M.; Caneparo V.; Generali E.; Sirotti S.; Isailovic N.; Guidelli G.M.; Ceribelli A.; Fabbroni M.; Simpatico A.; Cantarini L.; Gisondi P.; Idolazzi L.; Gariglio M.; Selmi C.
The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes
2018-01-01 Caneparo, Valeria; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD)
2017-01-01 Astegiano, M.; Vanni, E.; Finocchiaro, F.; Vernero, M.; Ribaldone, D.; Reggiani, S.; Caviglia, G.; De Andrea, M.; Caneparo, V.; Landolfo, S.; Gariglio, M.; Smedile, A.; Pellicano, R.
Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding
2020-01-01 Iannucci A.; Caneparo V.; Raviola S.; Debernardi I.; Colangelo D.; Miggiano R.; Griffante G.; Landolfo S.; Gariglio M.; de Andrea M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis. | 2016 | Alunno, Alessia ; Caneparo, Valeria; Bistoni, Onelia; Caterbi, Sara; Terenzi, Riccardo; Gariglio, Marisa; Bartoloni, Elena; Manzo, Antonio; Landolfo, Santo; Gerli, Roberto | |
| Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy | 2016 | Caneparo, Valeria; Pastorelli, Luca; Pisani, Laura Francesca; Bruni, Barbara; Prodam, Flavia; Boldorini, Renzo; Roggenbuck, Dirk; Vecchi, Maurizio; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco | |
| IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data | 2019 | Marino, Sonia; Gualtierotti, Roberta; Caneparo, Valeria; De Andrea, Marco; Gariglio, Marisa; Meroni, Pier Luigi; Bossi, Eleonora; Spadari, Francesco | |
| IFI16 Autoantibodies | 2013 | Dell’Oste, Valentina; Caneparo, Valeria; De Andrea Marco; Gariglio, Marisa; Landolfo, Santo | |
| Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease | 2019 | Manfredi, Marcello; Conte, Eleonora; Barberis, Elettra; Buzzi, Arianna; Robotti, Elisa; Caneparo, Valeria; Cecconi, Daniela; Brandi, Jessica; Vanni, Ester; Finocchiaro, Marco; Astegiano, Marco; Gariglio, Marisa; Marengo, Emilio; De Andrea, Marco | |
| Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands. | 2015 | Alunno, Alessia; Caneparo, Valeria; Carubbi, A; Bistoni, O; Caterbi; Gariglio, M; Bartoloni, E; Landolfo, S; Gerli, R; | |
| Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? | 2015 | Alunno, Alessia; Caneparo, Valeria; Carubbi, Francesco; Bistoni, Onelia; Caterbi, Sara; Bartoloni, Elena; Giacomelli, Roberto; Gariglio, Marisa; Landolfo, Santo; Gerli, Roberto | |
| P178 Validation of the clinical utility of IFI16-based markers in IBD | 2017 | V. Caneparo, L. Pastorelli, E. Vanni, D. Roggenbuck, R. Boldorini, M. Astegiano, M. Vecchi, S. Landolfo, M. Gariglio, M. De Andrea | |
| P600 Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD | 2018 | Caneparo, V; Verstockt, B; Vermeire, S; Landolfo, S; Gariglio, M; De Andrea, M | |
| Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study | 2021 | Griffante G.; Chandel S.; Ferrante D.; Caneparo V.; Capello D.; Bettio V.; Borgogna C.; Aleni C.; Esposito S.; Sarro A.; Vasile A.; Comba M.; Testa T.; Cotrupi G.; De Andrea M.; Bortoluzzi S.; Gariglio M. | |
| Relevance of Interferon-Inducible Protein-16 Rather than Anti-Interferon-Inducible Protein-16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren's Syndrome: Comment on the Article by Baer et al. | 2017 | Alunno, A; Bartoloni, E; Bistoni, O; Gerli, R; Caneparo, V; Carubbi, F; Landolfo, S | |
| Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis | 2020 | De Andrea M.; De Santis M.; Caneparo V.; Generali E.; Sirotti S.; Isailovic N.; Guidelli G.M.; Ceribelli A.; Fabbroni M.; Simpatico A.; Cantarini L.; Gisondi P.; Idolazzi L.; Gariglio M.; Selmi C. | |
| The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes | 2018 | Caneparo, Valeria; Landolfo, Santo; Gariglio, Marisa; De Andrea, Marco | |
| THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) | 2017 | Astegiano, M.; Vanni, E.; Finocchiaro, F.; Vernero, M.; Ribaldone, D.; Reggiani, S.; Caviglia, G.; De Andrea, M.; Caneparo, V.; Landolfo, S.; Gariglio, M.; Smedile, A.; Pellicano, R. | |
| Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding | 2020 | Iannucci A.; Caneparo V.; Raviola S.; Debernardi I.; Colangelo D.; Miggiano R.; Griffante G.; Landolfo S.; Gariglio M.; de Andrea M. |